Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.

"Declarations Conflict of interestIP is an employee and equity holder in Oncompass Medicine Inc., and Genomate Health Inc. BV, JD, DT, EK, RD, DL, AD, MV, EV, PF, RSZ-D are employees of Oncompass Medicine Inc. All other authors declare no conflict interests. Ethical approvalParticipants or their parents or legal guardian signed consent for study participation after risks and benefits had been explained. Consents extend to the purposes of the study, the limitations of the tests and the understanding and approval of data storage, data analysis and management. Ethics approval was obtained from the National Institute of Pharmacy and Nutrition (OGYÉI/50268/2017) before conducting the study. Conflict of interest IP is an employee and equity holder in Oncompass Medicine Inc., and Genomate Health Inc. BV, JD, DT, EK, RD, DL, AD, MV, EV, PF, RSZ-D are employees of Oncompass Medicine Inc. All other authors declare no conflict interests."

"Funding Open access funding provided by Semmelweis University. Hungarian Innovation Agency under NVKP_16-1-2016-0005, KFI_16-1-2016-0048, NKFIH K_22 143021 and 2019-1.1.1-PIACI-KFI-2019-00367 projects, K_143021."